Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


20.05.2019

1 Am J Clin Oncol
2 Ann Oncol
1 Ann Surg
1 Ann Surg Oncol
3 Anticancer Res
5 BMC Cancer
2 BMJ
1 Br J Cancer
3 Breast Cancer
2 Breast Cancer Res
7 Breast Cancer Res Treat
8 Breast J
1 Cancer
2 Cancer Lett
1 Cancer Res
1 Clin Breast Cancer
1 Clin Cancer Res
1 Exp Cell Res
2 Gene
5 Int J Cancer
2 Int J Oncol
2 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
3 J Natl Cancer Inst
1 J Pathol
1 J Surg Oncol
2 Lancet Glob Health
2 Lancet Oncol
1 N Engl J Med
3 Nat Rev Cancer
1 Nat Rev Clin Oncol
1 Oncology
1 Pathology
1 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. GANDHI C, Butler E, Pesek S, Kwait R, et al
    Sexual Dysfunction in Breast Cancer Survivors: Is it Surgical Modality or Adjuvant Therapy?
    Am J Clin Oncol. 2019 May 13. doi: 10.1097/COC.0000000000000552.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. LOIBL S, Untch M, Burchardi N, Huober J, et al
    A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple negative breast cancer - clinical results and biomarker analysis of GeparNuevo study.
    Ann Oncol. 2019 May 16. pii: 5490226. doi: 10.1093.
    PubMed     Text format     Abstract available

  3. FOULKES WD, Polak P
    Journey's End: the quest for BRCA-like hereditary breast cancer genes is nearly over.
    Ann Oncol. 2019 May 15. pii: 5489599. doi: 10.1093.
    PubMed     Text format    


    Ann Surg

  4. FITZAL F, Bjelic-Radisic V, Knauer M, Steger G, et al
    Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
    Ann Surg. 2019;269:1163-1169.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  5. WHITWORTH P
    Response to: "Intact Excision of Breast Lesions Using BLES: Is There a Clinical Indication Yet?"
    Ann Surg Oncol. 2019;26:1950-1951.
    PubMed     Text format    


    Anticancer Res

  6. TANAKA Y, Kosaka Y, Waraya M, Yokota K, et al
    Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer.
    Anticancer Res. 2019;39:2289-2298.
    PubMed     Text format     Abstract available

  7. ATIYA HI, Dvorkin-Gheva A, Hassell J, Patel S, et al
    Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis.
    Anticancer Res. 2019;39:2277-2287.
    PubMed     Text format     Abstract available

  8. VOGEL C, Malter W, Morgenstern B, Ludwig S, et al
    The Role of Previous Therapies and Sites of Metastasis as Influencing Factors on Discordance of ER, PR and HER2 Status Between Primary and Metastasized Breast Cancer.
    Anticancer Res. 2019;39:2647-2659.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. YI Z, Ma F, Liu B, Guan X, et al
    Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study.
    BMC Cancer. 2019;19:442.
    PubMed     Text format     Abstract available

  10. VALE DB, Filho CC, Shinzato JY, Spreafico FS, et al
    Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis.
    BMC Cancer. 2019;19:432.
    PubMed     Text format     Abstract available

  11. MCANENA P, Tanriverdi K, Curran C, Gilligan K, et al
    Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    BMC Cancer. 2019;19:436.
    PubMed     Text format     Abstract available

  12. WANG K, Wang G, Huang S, Luo A, et al
    Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women.
    BMC Cancer. 2019;19:446.
    PubMed     Text format     Abstract available

  13. ZHENG A, Zhang L, Song X, Wang Y, et al
    Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.
    BMC Cancer. 2019;19:451.
    PubMed     Text format     Abstract available


    BMJ

  14. DE BLOK CJM, Wiepjes CM, Nota NM, van Engelen K, et al
    Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.
    BMJ. 2019;365:l1652.
    PubMed     Text format     Abstract available

  15. MAHASE E
    Hormone therapy increases breast cancer risk in transgender women, study finds.
    BMJ. 2019;365:l2221.
    PubMed     Text format    


    Br J Cancer

  16. LIM B, Murthy RK, Lee J, Jackson SA, et al
    A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
    Br J Cancer. 2019 May 17. pii: 10.1038/s41416-019-0473.
    PubMed     Text format     Abstract available


    Breast Cancer

  17. JONES LM, Stoner L, Brown C, Baldi JC, et al
    Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00975.
    PubMed     Text format     Abstract available

  18. LI N, Lv XH, Wang X, Wang RT, et al
    Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes.
    Breast Cancer. 2019 May 13. pii: 10.1007/s12282-019-00976.
    PubMed     Text format     Abstract available

  19. ROBERTSON JFR, Jiang Z, Di Leo A, Ohno S, et al
    A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer.
    Breast Cancer. 2019 May 11. pii: 10.1007/s12282-019-00973.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  20. LAAKMANN E, Witzel I, Fasching PA, Rezai M, et al
    Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
    Breast Cancer Res. 2019;21:60.
    PubMed     Text format     Abstract available

  21. GRINDE MT, Hilmarsdottir B, Tunset HM, Henriksen IM, et al
    Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Breast Cancer Res. 2019;21:61.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  22. AWAN AA, Hutton B, Hilton J, Mazzarello S, et al
    De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis.
    Breast Cancer Res Treat. 2019 May 11. pii: 10.1007/s10549-019-05265.
    PubMed     Text format     Abstract available

  23. GOLDBERG M, Sutradhar R, Paszat L, Whelan TJ, et al
    Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.
    Breast Cancer Res Treat. 2019 May 10. pii: 10.1007/s10549-019-05266.
    PubMed     Text format     Abstract available

  24. SHENG JY, Blackford AL, Bardia A, Venkat R, et al
    Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy.
    Breast Cancer Res Treat. 2019 May 11. pii: 10.1007/s10549-019-05270.
    PubMed     Text format     Abstract available

  25. LI YR, Ro V, Steel L, Carrigan E, et al
    Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer.
    Breast Cancer Res Treat. 2019 May 13. pii: 10.1007/s10549-019-05267.
    PubMed     Text format     Abstract available

  26. PILEVARZADEH M, Amirshahi M, Afsargharehbagh R, Rafiemanesh H, et al
    Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis.
    Breast Cancer Res Treat. 2019 May 13. pii: 10.1007/s10549-019-05271.
    PubMed     Text format     Abstract available

  27. SILBERHOLZ J, Bertsimas D, Vahdat L
    Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis.
    Breast Cancer Res Treat. 2019 May 14. pii: 10.1007/s10549-019-05208.
    PubMed     Text format     Abstract available

  28. ZHANG JY, Liao YH, Lin Y, Liu Q, et al
    Effects of tea consumption and the interactions with lipids on breast cancer survival.
    Breast Cancer Res Treat. 2019 May 16. pii: 10.1007/s10549-019-05253.
    PubMed     Text format     Abstract available


    Breast J

  29. ARCIERO C, Liu Y, Gillespie T, Subhedar P, et al
    Surgery and survival in patients with stage IV breast cancer.
    Breast J. 2019 May 13. doi: 10.1111/tbj.13296.
    PubMed     Text format     Abstract available

  30. SELLAM Y, Shahadi ID, Gelernter I, Zippel D, et al
    Local recurrence of breast cancer: Salvage lumpectomy as an option for local treatment.
    Breast J. 2019 May 13. doi: 10.1111/tbj.13290.
    PubMed     Text format     Abstract available

  31. BAO J, Donovan C, Amersi F, Zhang X, et al
    Outcomes in patients with small node-negative invasive breast cancer.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13288.
    PubMed     Text format     Abstract available

  32. PLATKO K, Haas-Neill S, Aziz T, Al-Nedawi K, et al
    The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13309.
    PubMed     Text format     Abstract available

  33. COSTA NCD, Morsch DM, Opperman CP, Spritzer PM, et al
    Biological features of breast cancer according to age at diagnosis in southern Brazil: An analysis of retrospective data of 1128 women.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13327.
    PubMed     Text format    

  34. YANG K, Park W, Ju SG, Chung Y, et al
    Heart-sparing radiotherapy with three-dimensional printing technology after mastectomy for patients with left breast cancer.
    Breast J. 2019 May 11. doi: 10.1111/tbj.13304.
    PubMed     Text format     Abstract available

  35. MILOSEVIC ZC, Nadrljanski MM, Mijalkovic SD
    Sequelae of breast pyoderma gangrenosum associated with ulcerative colitis: Impact on breast cancer screening.
    Breast J. 2019 May 11. doi: 10.1111/tbj.13318.
    PubMed     Text format    

  36. KOVAC M, Kovac Z, Tomasevic Z, Tomic B, et al
    Breast cancer and recurrent thrombosis - Results from prospective single center study.
    Breast J. 2019 May 12. doi: 10.1111/tbj.13326.
    PubMed     Text format    


    Cancer

  37. NYROP KA, Deal AM, Reeder-Hayes KE, Shachar SS, et al
    Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
    Cancer. 2019 May 15. doi: 10.1002/cncr.32175.
    PubMed     Text format     Abstract available


    Cancer Lett

  38. SUN Q, Wang Y, Desgrosellier JS
    Combined Bcl-2/Src inhibition synergize to deplete stem-like breast cancer cells.
    Cancer Lett. 2019 May 9. pii: S0304-3835(19)30280.
    PubMed     Text format     Abstract available

  39. MO D, Jiang P, YiningYang, Mao X, et al
    A tRNA fragment, 5'-tiRNA(Val), suppresses the Wnt/beta-Catenin signaling pathway by targeting FZD3 in breast cancer.
    Cancer Lett. 2019 May 9. pii: S0304-3835(19)30283.
    PubMed     Text format     Abstract available


    Cancer Res

  40. RON A, Dean-Ben XL, Gottschalk S, Razansky D, et al
    Volumetric optoacoustic imaging unveils high-resolution patterns of acute and cyclic hypoxia in a murine model of breast cancer.
    Cancer Res. 2019 May 16. pii: 0008-5472.CAN-18-3769.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  41. GORNES H, Cabarrou B, Jouve E, Franchet C, et al
    Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer.
    Clin Breast Cancer. 2019 Apr 17. pii: S1526-8209(19)30018.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  42. STEENBRUGGEN TG, van Seijen M, Janssen LM, van Ramshorst MS, et al
    Prognostic value of residual disease after neoadjuvant therapy in HER2+ breast cancer evaluated by Residual Cancer Burden, Neoadjuvant Response Index & Neo-Bioscore.
    Clin Cancer Res. 2019 May 10. pii: 1078-0432.CCR-19-0560.
    PubMed     Text format     Abstract available


    Exp Cell Res

  43. TAN S, Natasa B, Wong ESP, Lin VCL, et al
    Ligand-activated progesterone receptor B activates transcription factor EB to promote autophagy in human breast cancer cells MCF-7.
    Exp Cell Res. 2019 May 14. pii: S0014-4827(19)30255.
    PubMed     Text format     Abstract available


    Gene

  44. XU X, Yang J, Zhou W, Wang L, et al
    Genetic variations within alternative splicing associated genes are associated with breast cancer susceptibility in Chinese women.
    Gene. 2019 May 9. pii: S0378-1119(19)30484-6. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available

  45. KASA P, Farran B, Prasad GLV, Nagaraju GP, et al
    Aquaporins in female specific cancers.
    Gene. 2019;700:60-64.
    PubMed     Text format     Abstract available


    Int J Cancer

  46. RANINGA PV, Lee A, Sinha D, Shih YY, et al
    Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
    Int J Cancer. 2019 May 15. doi: 10.1002/ijc.32410.
    PubMed     Text format     Abstract available

  47. ENGEL C, Fischer C, Zachariae S, Bucksch K, et al
    Breast cancer risk in BRCA1/2 mutation carriers and non-carriers under prospective intensified surveillance.
    Int J Cancer. 2019 May 13. doi: 10.1002/ijc.32396.
    PubMed     Text format     Abstract available

  48. JACOT W, Heudel PE, Fraisse J, Gourgou S, et al
    Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.
    Int J Cancer. 2019 May 14. doi: 10.1002/ijc.32402.
    PubMed     Text format     Abstract available

  49. KUMARAN M, Ghosh S, Joy AA, Mackey JR, et al
    Fine-mapping of a novel premenopausal breast cancer susceptibility locus at Chr4q31.22 in Caucasian women and validation in African and Chinese women.
    Int J Cancer. 2019 May 14. doi: 10.1002/ijc.32407.
    PubMed     Text format     Abstract available

  50. JOKO-FRU WY, Miranda-Filho A, Soerjomataram I, Egue M, et al
    Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index (HDI): A population-based registry study.
    Int J Cancer. 2019 May 14. doi: 10.1002/ijc.32406.
    PubMed     Text format     Abstract available


    Int J Oncol

  51. DING Y, He J, Huang J, Yu T, et al
    Harmine induces anticancer activity in breast cancer cells via targeting TAZ.
    Int J Oncol. 2019;54:1995-2004.
    PubMed     Text format     Abstract available

  52. NAKAYAMA Y, Mimura K, Tamaki T, Shiraishi K, et al
    PhosphoSTAT1 expression as a potential biomarker for antiPD1/antiPDL1 immunotherapy for breast cancer.
    Int J Oncol. 2019;54:2030-2038.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  53. GROSS JP, Whelan TJ, Parulekar WR, Chen BE, et al
    Development and validation of a nomogram to predict lymphedema following axillary surgery and radiotherapy in women with breast cancer from the NCIC CTG MA.20 randomized trial.
    Int J Radiat Oncol Biol Phys. 2019 May 11. pii: S0360-3016(19)30702.
    PubMed     Text format     Abstract available

  54. HAFFTY BG, McCall LM, Ballman KV, Buchholz TA, et al
    Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2019 May 11. pii: S0360-3016(19)30722.
    PubMed     Text format     Abstract available


    J Clin Oncol

  55. FABIAN CJ
    Will a Low-Dose Option Improve Uptake of Tamoxifen for Breast Cancer Risk Reduction?
    J Clin Oncol. 2019 May 13:JCO1900656. doi: 10.1200/JCO.19.00656.
    PubMed     Text format    

  56. UNTCH M, Jackisch C, Schneeweiss A, Schmatloch S, et al
    NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto.
    J Clin Oncol. 2019 May 13:JCO1801842. doi: 10.1200/JCO.18.01842.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  57. SU Y, Huang J, Wang S, Unger JM, et al
    The Effects of Ganglioside-Monosialic Acid in Taxane-induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
    J Natl Cancer Inst. 2019 May 15. pii: 5489913. doi: 10.1093.
    PubMed     Text format     Abstract available

  58. LIN CH, Yap YS, Lee KH, Im SA, et al
    Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians versus the US Population.
    J Natl Cancer Inst. 2019 May 15. pii: 5489914. doi: 10.1093.
    PubMed     Text format     Abstract available

  59. GOMEZ SL, Yao S, Kushi LH, Kurian AW, et al
    Is breast cancer in Asian and Asian American women a different disease?
    J Natl Cancer Inst. 2019 May 15. pii: 5489912. doi: 10.1093.
    PubMed     Text format    


    J Pathol

  60. SALVADOR F, Llorente A, Gomis RR
    From latency to overt bone metastasis in breast cancer: Potential for treatment and prevention.
    J Pathol. 2019 May 16. doi: 10.1002/path.5292.
    PubMed     Text format     Abstract available


    J Surg Oncol

  61. CORSI F, Bossi D, Combi F, Papadopoulou O, et al
    Radio-guided vs clip-guided localization of nonpalpable mass-like lesions of the breast from a screened population: A propensity score-matched study.
    J Surg Oncol. 2019;119:916-924.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  62. DOS-SANTOS-SILVA I, De Stavola BL, Renna NL Junior, Nogueira MC, et al
    Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis.
    Lancet Glob Health. 2019;7:e784-e797.
    PubMed     Text format     Abstract available

  63. YIP CH
    Downstaging is more important than screening for asymptomatic breast cancer.
    Lancet Glob Health. 2019;7:e690-e691.
    PubMed     Text format    


    Lancet Oncol

  64. HOFVIND S, Holen AS, Aase HS, Houssami N, et al
    Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
    Lancet Oncol. 2019 May 8. pii: S1470-2045(19)30161.
    PubMed     Text format     Abstract available

  65. VARATHARAJAH R
    Breast cancer screening by visually impaired women.
    Lancet Oncol. 2019 May 10. pii: S1470-2045(19)30290.
    PubMed     Text format    


    N Engl J Med

  66. ANDRE F, Ciruelos E, Rubovszky G, Campone M, et al
    Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
    N Engl J Med. 2019;380:1929-1940.
    PubMed     Text format     Abstract available


    Nat Rev Cancer

  67. DART A
    Stressed out!
    Nat Rev Cancer. 2019;19:248.
    PubMed     Text format    

  68. HARJES U
    Renovation in progress.
    Nat Rev Cancer. 2019;19:246.
    PubMed     Text format    

  69. WRIGHTON KH
    Trafficking signals for metastasis.
    Nat Rev Cancer. 2019;19:127.
    PubMed     Text format    


    Nat Rev Clin Oncol

  70. CUZICK J
    Predicting late recurrence in ER-positive breast cancer.
    Nat Rev Clin Oncol. 2019 May 15. pii: 10.1038/s41571-019-0228.
    PubMed     Text format    


    Oncology

  71. PAGLIARO G, Bernardini F
    A Specific Type of Tibetan Medicine Meditation for Women with Breast Cancer: A Pilot Survey.
    Oncology. 2019 May 15:1-5. doi: 10.1159/000500676.
    PubMed     Text format     Abstract available


    Pathology

  72. FARSHID G, Bilous M, Morey A, Fox S, et al
    ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia.
    Pathology. 2019 May 7. pii: S0031-3025(18)30615.
    PubMed     Text format     Abstract available


    PLoS One

  73. KIM N, Chung W, Eum HH, Lee HO, et al
    Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    PLoS One. 2019;14:e0217196.
    PubMed     Text format     Abstract available


    Radiology

  74. KORHONEN KE, Conant EF, Cohen EA, Synnestvedt M, et al
    Breast Cancer Conspicuity on Simultaneously Acquired Digital Mammographic Images versus Digital Breast Tomosynthesis Images.
    Radiology. 2019 May 14:182027. doi: 10.1148/radiol.2019182027.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: